|
|
Subpopulations of Human Dendritic Cells
|
5R01CA078846-10
|
$292,811
|
$219,608
|
Banchereau, Jacques
|
BAYLOR RESEARCH INSTITUTE
|
|
|
Diversification of Cytotoxic Effector Cells Via LPS-activated DCs
|
1R01CA129350-01A2
|
$526,521
|
$526,521
|
PALUCKA, A
|
BAYLOR RESEARCH INSTITUTE
|
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-25
|
$453,250
|
$4,533
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-10
|
$128,678
|
$10,294
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Expression and Function of Tob in T Lymphocytes
|
7R01CA104596-04
|
$318,352
|
$15,918
|
BOUSSIOTIS, VASSILIKI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Control of Protein Translation in Cancer Pathogenesis
|
7U01CA084292-10
|
$697,531
|
$174,383
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Pathogenesis of Epstein-Barr Virus Infection
|
5R01CA068051-13
|
$407,881
|
$20,394
|
WANG, FREDERICK
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Natural Killer Cell Growth and Development
|
5R01CA041268-23
|
$337,399
|
$253,049
|
BIRON, CHRISTINE
|
BROWN UNIVERSITY
|
|
|
Carle Cancer Center Community Clinical Oncology Program
|
2U10CA035195-25
|
$855,703
|
$8,557
|
ROWLAND, KENDRITH
|
CARLE CLINIC ASSOCIATION, P C
|
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-34
|
$417,899
|
$33,432
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Research Oncology Training Grant
|
5T32CA059366-15
|
$167,142
|
$16,714
|
DISTELHORST, CLARK
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-18S3
|
$234,254
|
$4,685
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-19S1
|
$72,416
|
$1,448
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-19S2
|
|
$0
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-19
|
$5,104,000
|
$102,080
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
T Cell Immunity in Endemic Burkitt Lymphoma
|
1R01CA134051-01A2
|
$485,971
|
$242,986
|
MOORMANN, ANN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Cedar Rapids Oncology Project
|
2U10CA052352-19
|
$575,627
|
$11,513
|
WIESENFELD, MARTIN
|
CEDAR RAPIDS ONCOLOGY PROJECT
|
|
|
Biological Function(s) of Maspin
|
5R01CA075681-10
|
$242,356
|
$121,178
|
HENDRIX, MARY
|
CHILDREN'S MEMORIAL HOSPITAL (CHICAGO)
|
|
|
Delaware/Christiana Care CCOP
|
5U10CA045418-22
|
$1,042,698
|
$10,427
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
|
Cancer Center Support Grant
|
2P30CA033572-25
|
$2,342,475
|
$23,425
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-25S1
|
$95,134
|
$951
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-25S2
|
$107,415
|
$1,074
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
City of Hope Southwest Oncology Group Clinical Trials
|
5U10CA046368-21
|
$315,196
|
$15,760
|
MORTIMER, JOANNE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Role of CEACAM1 in Epithelial Cell Polarization
|
5R01CA084202-08
|
$404,273
|
$101,068
|
Shively, John
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Role of IRF-1 in Tumor Suppression of Breast Cancer
|
7K08CA098403-05
|
$132,030
|
$92,421
|
YIM, JOHN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Southwest Oncology Group
|
5U10CA004919-49
|
$192,303
|
$9,615
|
BUDD, G
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
|
Tumor Induced Dysregulation of T Cell Immunity
|
5R01CA116255-03
|
$261,665
|
$13,083
|
FINKE, JAMES
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
|
Induction of IL-12 in DC by structurally-defined RNA
|
5R01CA100163-04
|
$229,214
|
$114,607
|
Koski, Gary
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
|
TCR Diagnostics in LGL Leukemia and Immune Cytopenias
|
5R01CA113972-04
|
$286,517
|
$28,652
|
Maciejewski, Jaroslaw
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
|
Therapeutic Modulation of COX-2-induced Immunosuppression in Metastatic RCC
|
5R21CA123854-02
|
$293,550
|
$293,550
|
RINI, BRIAN
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
|
Antiviral Actions of Interferons
|
5R01CA068782-22
|
$428,839
|
$428,839
|
SEN, GANES
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
|
Antiviral Mechanisms of 2-5A Dependent RNase L
|
5R01CA044059-24
|
$367,548
|
$183,774
|
Silverman, Robert
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
|
Role of RNase L in the Biology of Prostate Cancer
|
5R01CA103943-05
|
$297,398
|
$297,398
|
Silverman, Robert
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
|
IFNs and Cytokines: Signaling and Action
|
5P01CA062220-14
|
$1,949,778
|
$1,949,778
|
STARK, GEORGE
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
|
CCOP: Colorado Cancer Research Program
|
5U10CA067753-13
|
$873,364
|
$17,467
|
Pajon, Eduardo
|
COLORADO CANCER RESEARCH PROGRAM, INC.
|
|
|
Cancer Center Support Grant
|
2P30CA013696-35
|
$3,785,244
|
$37,852
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Stem Cells and Gastric Cancer
|
5R01CA120979-03
|
$448,475
|
$112,119
|
Wang, Timothy
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Columbus Community Clinical Oncology Program
|
5U10CA035261-25
|
$874,908
|
$17,498
|
KUEBLER, J
|
COLUMBUS COMMUNITY CLINICAL ONCOLOGY PRG
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S1
|
$124,531
|
$1,245
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S2
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S3
|
$49,998
|
$500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S4
|
$143,383
|
$1,434
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S5
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-44
|
$11,641,774
|
$116,418
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
ECOG Statistical Office
|
5U10CA023318-32
|
$2,367,125
|
$189,370
|
GRAY, ROBERT
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Immunotherapy for Renal Cell Carcinoma
|
2R01CA095648-04A1
|
$394,585
|
$98,646
|
ERNSTOFF, MARC
|
DARTMOUTH COLLEGE
|
|
|
Dayton Clinical Oncology Program
|
5U10CA035090-26
|
$955,207
|
$9,552
|
Gross, Howard
|
DAYTON CLINICAL ONCOLOGY PROGRAM
|
|
|
Central Illinois Community Clinical Oncology Program
|
5U10CA045807-23
|
$1,053,633
|
$21,073
|
WADE, JAMES
|
DECATUR MEMORIAL HOSPITAL
|
|
|
Eastern Cooperative Oncology Group Chair's Office
|
5U10CA086802-10
|
$644,464
|
$51,557
|
COMIS, ROBERT
|
DREXEL UNIVERSITY
|
|
|
Duke Comp Cancer Ctr Core Support Grant
|
3P30CA014236-34S1
|
$40,000
|
$400
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Total relevant funding to Interferon for this search: $35,442,662
|
